[Clinical experiences with clonazepam with special regard to psychomotor seizures].
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy*; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous; D009207:Myoclonus / Q000188:drug therapy; D009574:Nitro Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000927:Anticonvulsants; D001570:Benzodiazepinones; D002722:Chlorobenzenes; D009574:Nitro Compounds
Klinische Erfahrungen mit Clonazepam unter besonderer Berücksichtigung psychomotorischer Anfälle.